NASDAQ Equity Snapshot

IRD Weekly Equity Report

Opus Genetics, Inc.

Interactive chart JSON snapshot
Latest Close 4.04 USD 12 Jun 2026
1W Return 0.2% latest completed week
4W Return -15.8% short-term follow-through
12W Return -8.0% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Opus Genetics, Inc. (IRD) is a pioneering biotechnology company dedicated to advancing gene therapies aimed at treating rare retinal diseases that compromise vision. By harnessing cutting-edge research and proprietary gene-editing technologies, Opus is committed to addressing pressing unmet medical needs and enhancing ocular health. With a strong pipeline complemented by ongoing clinical trials and strategic partnerships, the company is positioned to drive meaningful advancements in patient care, while simultaneously offering significant value creation opportunities for institutional investors seeking exposure in the innovative healthcare sector.

Snapshot

What the weekly tape is saying

IRD closed the latest completed week at 4.04 USD. The 4-week return is -15.8% and the 12-week return is -8.0%. Trend Signal is active, Market Dynamics is -0.82. Setup signature: Balanced read with a 42/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 11.1%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 92 Persistence of active Trend Signal over the last year and current streak.
Momentum 6 Blend of 4-week and 12-week follow-through.
Dynamics 17 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 36 Participation compared with the 13-week volume baseline.
Risk Control 1 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 2 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
3.64 USD
Vs Trend Line
11.1%
Fair Value
2.27 USD
Vs Fair Value
78.4%
52W High
5.81 USD
52W Low
0.90 USD
Drawdown
-30.5%
Range Position
63.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.2%
4W -15.8%
12W -8.0%
26W 71.2%
52W 316.5%

Trend read

Active Streak
44 weeks
52W Active Weeks
44
52W Active Breadth
84.6%
Sector Scope
US Healthcare
Sector Rank
516 of 1038
Sector Percentile
50.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.82
4W MD Change
-229.4%
Relative Strength
28.69
4W RS Change
-57.1%
Expectation
Positive
Probability
57.35%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.4M
13W Average
4.0M
52W Average
3.1M
Vs 13W
0.9x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
8.0%
52W Volatility
10.1%
Upside Weeks
32
Downside Weeks
18
Downside Breadth
34.6%
Avg Gain / Loss
9.4% / -7.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
NASDAQ
Country
US
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market Cap
354.9M

Opportunity signals

  • Trend Signal is active with a 44-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 4.04 USD 0.2% 3.64 USD 2.27 USD -0.82 28.69 3.4M On
5 Jun 2026 4.03 USD -7.6% 3.56 USD 2.26 USD -0.54 33.55 5.0M On
29 May 2026 4.36 USD 2.3% 3.50 USD 2.26 USD -0.22 40.34 3.3M On
22 May 2026 4.26 USD -11.3% 3.43 USD 2.26 USD 0.21 43.70 4.0M On
15 May 2026 4.80 USD -3.8% 3.35 USD 2.26 USD 0.63 66.93 5.8M On
8 May 2026 4.99 USD -2.9% 3.25 USD 2.25 USD 0.90 77.01 4.4M On
1 May 2026 5.14 USD -1.7% 3.15 USD 2.26 USD 1.08 97.21 5.8M On
24 Apr 2026 5.23 USD -9.0% 3.04 USD 2.27 USD 1.04 109.67 4.0M On
17 Apr 2026 5.75 USD 7.3% 2.93 USD 2.27 USD 1.00 143.45 2.8M On
10 Apr 2026 5.36 USD 17.8% 2.79 USD 2.26 USD 1.00 150.41 4.1M On
2 Apr 2026 4.55 USD 4.6% 2.66 USD 2.26 USD 1.13 131.20 1.9M On
27 Mar 2026 4.35 USD -0.9% 2.55 USD 2.26 USD 1.38 137.54 2.2M On
20 Mar 2026 4.39 USD -12.7% 2.44 USD 2.26 USD 1.57 139.88 5.0M On
13 Mar 2026 5.03 USD 2.9% 2.34 USD 2.26 USD 1.61 177.79 7.1M On